Total Raised

$733.29M

Investors Count

12

Deal Terms

5

Investments

1

Funding, Valuation & Revenue

8 Fundings

Auris Health has raised $733.29M over 8 rounds.

Auris Health's latest funding round was a Acquired for on February 13, 2019.

Auris Health's valuation in August 2017 was $1,280M.

Auris Health's latest post-money valuation is from February 2019.

Sign up for a free demo to see Auris Health's valuations in February 2019 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/13/2019

Acquired

$XXM

0

FY undefined

7

11/28/2018

Series E

$XXM

$XXM

0

FY undefined

10

8/4/2017

Series D

$XXM

$1,280M

0

FY undefined

10

8/9/2016

Series C

$XXM

$XXM

0

FY undefined

10

9/23/2015

Series B

$XXM

$XXM

0

FY undefined

10

Date

2/13/2019

11/28/2018

8/4/2017

8/9/2016

9/23/2015

Round

Acquired

Series E

Series D

Series C

Series B

Amount

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$1,280M

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

7

10

10

10

10

Start free trial
New call-to-action

Auris Health Deal Terms

5 Deal Terms

Auris Health's deal structure is available for 5 funding rounds, including their Acquired from February 13, 2019.

Round

Acquired

Series D

Series C

Series B

Series A

Funding Date

$XXM

$XXM

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

$XXM

$XXM

$XXM

Dividend Rate

$XXM

$XXM

$XXM

Liquidation Preferences

$XXM

$XXM

$XXM

Liquidation Price

Participation

Conversion Price

Anti Dilution

$XXM

$XXM

$XXM

General Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$XXM

$XXM

$XXM

$XXM

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Auris Health Investors

12 Investors

Auris Health has 12 investors. Johnson & Johnson invested in Auris Health's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/13/2019

2/13/2019

1
Acquired

Corporation

New Jersey

3/31/2014

11/28/2018

Lux Capital
5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Venture Capital

New York

3/31/2014

11/28/2018

5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Venture Capital

Texas

00/00/0000

00/00/0000

Viking Global Investors

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

PFM Health Sciences

Subscribe to see more

Venture Capital

California

First funding

2/13/2019

3/31/2014

3/31/2014

00/00/0000

00/00/0000

Last Funding

2/13/2019

11/28/2018

11/28/2018

00/00/0000

00/00/0000

Investor

Lux Capital

Viking Global Investors

PFM Health Sciences

Rounds

1
Acquired
5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)
5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Asset/Investment Management

Venture Capital

Location

New Jersey

New York

Texas

New York

California

Auris Health Acquisitions

1 Acquisition

Auris Health acquired 1 company. Their latest acquisition was Hansen Medical on April 20, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/20/2016

Other Venture Capital

$XXM

$57.8M

Acquired

5

Date

4/20/2016

Investment Stage

Other Venture Capital

Companies

Valuation

$XXM

Total Funding

$57.8M

Note

Acquired

Sources

5

Auris Health Investments

1 Investments

Auris Health has made 1 investments. Their latest investment was in Qool Therapeutics as part of their Series B on November 08, 2017.

CBI Logo

Auris Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2017

Series B

Qool Therapeutics

$13.96M

Yes

1

Date

11/8/2017

Round

Series B

Company

Qool Therapeutics

Amount

$13.96M

New?

Yes

Co-Investors

Sources

1

New call-to-action

Compare Auris Health to Competitors

Asensus Surgical Logo
Asensus Surgical

Asensus Surgical provides robotic-assisted surgical technology and digital laparoscopic systems within the healthcare sector. The company offers products aimed at improving surgeon control and addressing variability during surgical procedures, utilizing augmented intelligence and real-time insights. Asensus Surgical serves the healthcare industry, targeting surgeons and hospital administrators. Asensus Surgical was formerly known as TransEnterix. It was founded in 2006 and is based in Durham, North Carolina.

CMR Surgical Logo
CMR Surgical

CMR Surgical operates as a global medical devices company that specializes in surgical robotics within the healthcare industry. The company offers Versius, a surgical robot designed for robotic minimal access surgery. CMR Surgical collaborates with healthcare professionals to improve the accessibility and affordability of robotic-assisted surgical procedures. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a medical device company that develops robotic-assisted technologies for cancer treatment within the interventional oncology sector. The company's main offering, the Epione® platform, is designed to plan, target, deliver, and confirm tumor ablation using robotics and image fusion technology. Quantum Surgical's solutions cater to the healthcare sector, providing tools for clinicians to perform procedures on inoperable or hard-to-reach tumors. It was founded in 2017 and is based in Montpellier, France.

Activ Surgical Logo
Activ Surgical

Activ Surgical focuses on intraoperative surgical intelligence within the medical technology sector. The company offers products that provide visual insights and information to surgeons, allowing them to see physiological structures and functions during surgery. These products integrate with existing surgical systems and are compatible with minimally invasive procedures. Activ Surgical was formerly known as OMNIBOROS, INC. It was founded in 2017 and is based in Boston, Massachusetts.

Theator Logo
Theator

Theator operates within the healthcare technology sector and focuses on its surgical intelligence platform. The platform captures, manages, and analyzes surgical video data using artificial intelligence (AI) to improve surgical quality and efficiency. It serves hospitals and healthcare providers and integrates surgical video with patient outcomes and operational analytics. It was founded in 2018 and is based in Palo Alto, California.

A
APACMed

Asia Pacific Medical Technology Association (APACMed) operates as a trade association and represents the medical devices and in-vitro diagnostics industry in Asia Pacific. APACMed engages in various activities, such as government affairs, market access, legal and compliance, regulatory affairs, and supporting digital health initiatives. It was founded in 2014 and is based in Singapore.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.